Sanofi (SNYNF)
OTCMKTS
· Delayed Price · Currency is USD
94.35
-0.40 (-0.42%)
Dec 23, 2024, 3:00 PM EST
Sanofi Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 45,566 | 43,070 | 42,997 | 37,761 | 36,041 | 36,126 | Upgrade
|
Other Revenue | 2,879 | 2,963 | 2,392 | 1,414 | 1,328 | 1,505 | Upgrade
|
Revenue | 48,445 | 46,033 | 45,389 | 39,175 | 37,369 | 37,631 | Upgrade
|
Revenue Growth (YoY) | 6.01% | 1.42% | 15.86% | 4.83% | -0.70% | 5.48% | Upgrade
|
Cost of Revenue | 14,962 | 14,216 | 13,692 | 12,251 | 12,106 | 11,976 | Upgrade
|
Gross Profit | 33,483 | 31,817 | 31,697 | 26,924 | 25,263 | 25,655 | Upgrade
|
Selling, General & Admin | 10,945 | 10,765 | 10,539 | 9,599 | 9,448 | 9,967 | Upgrade
|
Research & Development | 7,147 | 6,728 | 6,706 | 5,692 | 5,530 | 6,020 | Upgrade
|
Other Operating Expenses | 4,312 | 2,950 | 1,587 | 1,488 | 1,025 | 720 | Upgrade
|
Operating Expenses | 24,519 | 22,615 | 20,659 | 18,359 | 17,684 | 18,853 | Upgrade
|
Operating Income | 8,964 | 9,202 | 11,038 | 8,565 | 7,579 | 6,802 | Upgrade
|
Interest Expense | -690 | -527 | -394 | -362 | -459 | -544 | Upgrade
|
Interest & Investment Income | 531 | 546 | 173 | 3 | 37 | 91 | Upgrade
|
Earnings From Equity Investments | -63 | -115 | 68 | 39 | 359 | 255 | Upgrade
|
Currency Exchange Gain (Loss) | -2 | -2 | -4 | 2 | -6 | 1 | Upgrade
|
Other Non Operating Income (Expenses) | -665 | -665 | 37 | 70 | 144 | 236 | Upgrade
|
EBT Excluding Unusual Items | 8,075 | 8,439 | 10,918 | 8,317 | 7,654 | 6,841 | Upgrade
|
Merger & Restructuring Charges | -2,291 | -1,510 | -1,339 | -824 | -1,142 | -1,091 | Upgrade
|
Gain (Loss) on Sale of Investments | -1 | -1 | 1 | 3 | 7,388 | - | Upgrade
|
Gain (Loss) on Sale of Assets | 688 | 688 | 655 | 418 | 443 | 296 | Upgrade
|
Asset Writedown | -686 | -896 | 228 | -192 | -330 | -3,604 | Upgrade
|
Legal Settlements | - | - | - | - | - | 327 | Upgrade
|
Other Unusual Items | 273 | 318 | 27 | 115 | 124 | 238 | Upgrade
|
Pretax Income | 6,058 | 7,038 | 10,490 | 7,837 | 14,137 | 3,007 | Upgrade
|
Income Tax Expense | 1,509 | 1,602 | 2,006 | 1,558 | 1,807 | 121 | Upgrade
|
Earnings From Continuing Operations | 4,549 | 5,436 | 8,484 | 6,279 | 12,330 | 2,886 | Upgrade
|
Earnings From Discontinued Operations | - | - | - | - | - | -101 | Upgrade
|
Net Income to Company | 4,549 | 5,436 | 8,484 | 6,279 | 12,330 | 2,785 | Upgrade
|
Minority Interest in Earnings | -43 | -36 | -113 | -56 | -36 | -31 | Upgrade
|
Net Income | 4,506 | 5,400 | 8,371 | 6,223 | 12,294 | 2,754 | Upgrade
|
Net Income to Common | 4,506 | 5,400 | 8,371 | 6,223 | 12,294 | 2,754 | Upgrade
|
Net Income Growth | -50.30% | -35.49% | 34.52% | -49.38% | 346.41% | -36.04% | Upgrade
|
Shares Outstanding (Basic) | 1,251 | 1,252 | 1,252 | 1,253 | 1,254 | 1,250 | Upgrade
|
Shares Outstanding (Diluted) | 1,256 | 1,256 | 1,257 | 1,258 | 1,260 | 1,257 | Upgrade
|
Shares Change (YoY) | -0.05% | -0.04% | -0.08% | -0.17% | 0.24% | 0.15% | Upgrade
|
EPS (Basic) | 3.60 | 4.31 | 6.69 | 4.97 | 9.81 | 2.20 | Upgrade
|
EPS (Diluted) | 3.59 | 4.30 | 6.66 | 4.95 | 9.76 | 2.19 | Upgrade
|
EPS Growth | -50.24% | -35.44% | 34.55% | -49.28% | 345.73% | -36.15% | Upgrade
|
Free Cash Flow | - | 8,539 | 8,920 | 9,044 | 6,164 | 6,392 | Upgrade
|
Free Cash Flow Per Share | - | 6.80 | 7.10 | 7.19 | 4.89 | 5.08 | Upgrade
|
Dividend Per Share | - | 3.760 | 3.560 | 3.330 | 3.200 | 3.150 | Upgrade
|
Dividend Growth | - | 5.62% | 6.91% | 4.06% | 1.59% | 2.61% | Upgrade
|
Gross Margin | 69.12% | 69.12% | 69.83% | 68.73% | 67.60% | 68.18% | Upgrade
|
Operating Margin | 18.50% | 19.99% | 24.32% | 21.86% | 20.28% | 18.08% | Upgrade
|
Profit Margin | 9.30% | 11.73% | 18.44% | 15.89% | 32.90% | 7.32% | Upgrade
|
Free Cash Flow Margin | - | 18.55% | 19.65% | 23.09% | 16.49% | 16.99% | Upgrade
|
EBITDA | 12,503 | 12,520 | 14,062 | 11,251 | 10,466 | 10,113 | Upgrade
|
EBITDA Margin | 25.81% | 27.20% | 30.98% | 28.72% | 28.01% | 26.87% | Upgrade
|
D&A For EBITDA | 3,539 | 3,318 | 3,024 | 2,686 | 2,887 | 3,311 | Upgrade
|
EBIT | 8,964 | 9,202 | 11,038 | 8,565 | 7,579 | 6,802 | Upgrade
|
EBIT Margin | 18.50% | 19.99% | 24.32% | 21.86% | 20.28% | 18.08% | Upgrade
|
Effective Tax Rate | 24.91% | 22.76% | 19.12% | 19.88% | 12.78% | 4.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.